Michael H. Malim

35.1k citations

180 papers · 24.3k indexed · 13 hit papers · h-index 78

Impact in

Virology top 0.01%
- HIV Research and Treatment
Infectious Diseases top 0.05%
- HIV/AIDS drug development and treatment

Papers in

Virology 121
- HIV Research and Treatment 121
Infectious Diseases 75
- HIV/AIDS drug development and treatment 52
- SARS-CoV-2 and COVID-19 Research 17

Co-authors: Bryan R. Cullen Ann M. Sheehy Nathan Gaddis Joachim Hauber Kate N. Bishop Michael Emerman Jonathan Choi Rebecca K. Holmes
Journals: Journal of Virology (50 papers)PLoS Pathogens (10 papers)Nature (9 papers)Cell (7 papers)Proceedings of the National Academy of Sciences (7 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Michael H. Malim

179 papers receiving 23.9k citations

Hit Papers

13 papers align trajectories log scale

Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia 2021 · 281 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Nature
2016 Nature
2013 Nature
2012 Cold Spring Harbor Perspectives in Medicine
2004 Current Biology
2003 Cell
2003 Nature Medicine
2002 Nature
2000 Journal of Virology
1998 Annual Review of Microbiology
1997 Proceedings of the National Academy of Sciences
1989 Nature
1989 Cell

Peers

Countries citing papers authored by Michael H. Malim

Since Specialization

Citations

This map shows the geographic impact of Michael H. Malim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. Malim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. Malim more than expected).

Fields of papers citing papers by Michael H. Malim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael H. Malim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. Malim. The network helps show where Michael H. Malim may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael H. Malim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael H. Malim Line = papers co-authored together Michael H. Malim links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort Vaccines ·Eduardo B. Piedra Escudero, 慶一徳岡, Joseph Ssebwana Katende, T. W. Chaundy, Luis Alberto Vera Zamora, 晴子貞閑, Carl Graham, Jeffrey Seow, Katie J. Doores, Michael H. Malim, Julie Fox, Pontiano Kaleebu, Jennifer Serwanga	2025	1
2	Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages Nature Communications ·Suzanne Pickering, Harry Wilson, I.V. Bystrova, Marianne Perera, Jeffrey Seow, Carl Graham, Nathalia Almeida, Kanae Noji, Tom Williams, Marcela Cimflová, Helena Winstone, Abd el Malik Rahmani, Rui Pedro Galão, Luke B. Snell, Katie J. Doores, Michael H. Malim, Stuart J. D. Neil	2024	1
3	Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein Nature Communications ·Valeria Calvaresi, Antoni G. Wrobel, Dwi Erlina Susanti, Paul Lepe, Katie J. Doores, Richard T. Bradshaw, A. Graceson, D.J. Benton, Chloë Roustan, Eamonn Reading, Michael H. Malim, S.J. Gamblin, Argyris Politis	2023	32
4	Cross-Linking Mass Spectrometry Uncovers Interactions Between High-Density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein Molecular & Cellular Proteomics ·Sean A. Burnap, Ana Maria Ortega‐Prieto, Jose M. Jiménez-Guardeño, Hashim Ali, Kaloyan Takov, Matthew Fish, Manu Shankar‐Hari, Mauro Giacca, Michael H. Malim, Manuel Mayr	2023	6
5	Long-COVID fatigue is not predicted by pre-pandemic plasma IL-6 levels in mild COVID-19 Inflammation Research ·Maxim B. Freidin, Nathan J. Cheetham, Emma L. Duncan, Claire J. Steves, Rose Bharath, Michael H. Malim, Niccolò Rossi, Janet M. Lord, Paul W. Franks, Alessandra Borsini, J. G. Cordey, Mario Falchi, Carmine M. Pariante, Frances M. K. Williams	2023	5
6	Homebrew: An economical and sensitive glassmilk-based nucleic-acid extraction method for SARS-CoV-2 diagnostics Cell Reports Methods ·Robert L. Page, M. Cleveland, Mattia Ficarelli, 李丹钢, K. Ansai, Thomas J. A. Maguire, Clément R. Bouton, María José Lista, Stuart J. D. Neil, Michael H. Malim, Mark Zuckerman, Hannah E. Mischo, Rocío T. Martínez-Núñez	2022	7
7	ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants Cell Reports ·Jeffrey Seow, Carl Graham, 松本崇宏, Thomas Lechmere, Thomas J. A. Maguire, Isabella Huettner, F. L. S., Hataf Khan, Suzanne Pickering, عبدالرحمن بن عبدالعزيز الشعيبي, Anele Waters, Christopher Ward, Christine Mant, Michael J. Pitcher, Jo Spencer, Julie Fox, Michael H. Malim, Katie J. Doores	2022	11
8	Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms Leukemia ·Patrick Harrington, Hugues de Lavallade, Katie J. Doores, 清苅谷, Jeffrey Seow, Carl Graham, Thomas Lechmere, Deepti Radia, Richard Dillon, Pan Lingyun, Fengbin Tian, Mamun Dornseifer, Jamie Saunders, Natalia Curto‐García, Jennifer O’Sullivan, Kavita Raj, Shahram Kordasti, Michael H. Malim, Claire Harrison, Donal P. McLornan	2021	31
9	Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia Nature ·Luca Braga, Hashim Ali, Ilaria Secco, Elena Chiavacci, Guilherme Neves, Daniel H. Goldhill, Rebecca Penn, Jose M. Jiménez-Guardeño, Ana Maria Ortega‐Prieto, Rossana Bussani, Antonio Cannatà, Hilda Sharifzadeh, Chiara Collesi, Edoardo Schneider, Daniele Arosio, Ajay M. Shah, William Barclay, Michael H. Malim, Juan Burrone, Mauro Giacca Hit paper breakdown →	2021	281
10	Minimal impact of ZAP on lentiviral vector production and transduction efficiency Molecular Therapy — Methods & Clinical Development ·V.V. Chorna, G. Scarselli, Mattia Ficarelli, Dorota Kmieć, Adrian W. Signell, E. Zurawicz, Corey Jermaine Henderson, Harry Wilson, Stuart J. D. Neil, Michael H. Malim, Conrad A. Vink, Chad M. Swanson	2021	2
11	Immunoproteasome activation enables human TRIM5α restriction of HIV-1 Nature Microbiology ·Jose M. Jiménez-Guardeño, Luis Apolonia, Gilberto Betancor, Michael H. Malim	2019	47
12	Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology Proceedings of the National Academy of Sciences ·Pierre Vantourout, Adam Laing, Martin J. Woodward, Iva Zlatareva, Luis Apolonia, Andrew W. Jones, Ambrosius P. Snijders, Michael H. Malim, Adrian Hayday	2018	120
13	New insights into an X-traordinary viral protein Frontiers in Microbiology ·Torsten Schaller, Hélène Bauby, K Greenfeld, Michael H. Malim, Caroline Goujon	2014	20
14	How Representative Are Research Tissue Biobanks of the Local Populations? Experience of the Infectious Diseases Biobank at King's College, London, UK Biopreservation and Biobanking ·Zisis Kozlakidis, Christine Mant, Barry Peters, Frank Post, Julie Fox, John Philpott‐Howard, C. Y. William Tong, Jonathan Edgeworth, Mark Peakman, Michael H. Malim, John Cason	2011	3
15	APOBEC3F Can Inhibit the Accumulation of HIV-1 Reverse Transcription Products in the Absence of Hypermutation Journal of Biological Chemistry ·Rebecca K. Holmes, Frits Koning, Kate N. Bishop, Michael H. Malim	2006	260
16	Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins Virology ·Hendrik Huthoff, Michael H. Malim	2005	46
17	Long HIV Type 1 Reverse Transcripts Can Accumulate Stably within Resting CD4 ⁺ T Cells While Short Ones Are Degraded AIDS Research and Human Retroviruses ·William J. Swiggard, Una O’Doherty, Oleksandr Pidluzhnyak, Deepa Jeyakumar, Michael H. Malim	2004	44
18	Importin β Can Mediate the Nuclear Import of an Arginine-Rich Nuclear Localization Signal in the Absence of Importin α Molecular and Cellular Biology ·Diana Palmeri, Michael H. Malim	1999	182
19	The HIV-1 Rev protein: prototype of a novel class of eukaryotic post-transcriptional regulators Trends in Biochemical Sciences ·Bryan R. Cullen, Michael H. Malim	1991	91
20	Complete Nucleotide Sequence of a Mouse VL30 Retro-Element Molecular and Cellular Biology ·Sally E. Adams, Peter D. Rathjen, Clive A. Stanway, Sandra M. Fulton, Michael H. Malim, Wilma Wilson, Jill E. Ogden, Linda A. King, Susan M. Kingsman, Alan J. Kingsman	1988	21

About Michael H. Malim

Michael H. Malim is a scholar working on Virology, Infectious Diseases, Immunology, Hepatology and Epidemiology, having authored 180 papers that have together received 24.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (121 papers), HIV/AIDS drug development and treatment (52 papers), Cytomegalovirus and herpesvirus research (34 papers), Immune Cell Function and Interaction (27 papers), RNA Research and Splicing (25 papers), interferon and immune responses (19 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Nuclear Structure and Function (15 papers). The work is most often cited by research in Virology (15.1k citations), Infectious Diseases (8.3k citations), Immunology (7.3k citations), Epidemiology (5.7k citations) and Molecular Biology (10.7k citations). Michael H. Malim has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Bryan R. Cullen, Ann M. Sheehy, Nathan Gaddis, Joachim Hauber, Kate N. Bishop, Michael Emerman, Jonathan Choi, Rebecca K. Holmes, Victoria W. Pollard and Jacob V. Maizel. Their work appears in journals such as Journal of Virology, PLoS Pathogens, Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact